The 10th International Workshop on Waldenstrom's Macroglobulinemia was held October 11-13, 2018 in New York City, USA. The following are the 8 posters presented by the Bing Center for Waldenstrom's Macroglobulinemia.

Click on the poster to download a full size PDF version. For more information about IWWM-10, please visit http://www.wmworkshop.org/

Ibrutinib for the Treatment of Bing-Neel Syndrome

G. Itchaki, J. Paludo, S. Ansell, L. Palomba, S. Treon ,J. Castillo

CXCR4^S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia

Joshua N. Gustine, Nicholas Tsakmaklis, Maria G. Demos, Amanda Kofides, Jiaji G. Chen, Xia Liu, Manit Munshi, Maria Luisa Guerrera, Gloria G. Chan, Christopher J. Patterson, Kirsten Meid, Toni Dubeau, Guang Yang, Jorge J. Castillo, Zachary R. Hunter, Steven P. Treon, and Lian Xu.

THE IMPACT OF CXCR4 MUTATION SUBTYPES IN THE RESPONSE AND PROGRESSION-FREE SURVIVAL OF PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA TREATED WITH IBRUTINIB

Jorge J. Castillo, Joshua N. Gustine, Kirsten Meid, Toni E. Dubeau, Lian Xu, Guang Yang, Zachary R. Hunter, Steven P. Treon

Impact of Ibrutinib Dose Intensity on Patient Outcomes in Previously Treated Waldenstrom Macroglobulinemia

Joshua N. Gustine, Kirsten Meid, Toni Dubeau, Patricia Severns, M. Lia Palomba, Ranjana H. Advani, Steven P. Treon, and Jorge J. Castillo

Patient-Reported Symptoms During Ibrutinib Holds: A Withdrawal Syndrome

Jorge J. Castillo, Joshua N. Gustine, Kirsten Meid, Toni Dubeau, Patricia Severns, and Steven P. Treon

TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenström macroglobulinemia

Joshua N. Gustine, Nicholas Tsakmaklis, Maria G. Demos, Amanda Kofides, Jiaji G. Chen, Xia Liu, Manit Munshi, Maria Luisa Guerrera, Gloria G. Chan, Christopher J. Patterson, Kirsten Meid, Toni Dubeau, Guang Yang, Zachary R. Hunter, Steven P. Treon, Jorge J. Castillo, and Lian Xu.

Acquired von Willebrand disease in patients with Waldenström macroglobulinemia

Jorge J. Castillo, Joshua N. Gustine, Kirsten Meid, Toni E. Dubeau, Patricia Severns, Steven P. Treon

Survival Rates and Clinical Characteristics of Young Patients with Waldenström Macroglobulinemia

Amaara Babwah, MS, Joshua Gustine, MPH, Kirsten Meid, MPH, Toni Dubeau, NP, Patricia Severns, NP, Steven P. Treon, MD, PhD and Jorge J. Castillo, MD